Patents by Inventor Claudia Diefenbach

Claudia Diefenbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONS
    Publication number: 20230135671
    Abstract: Genes selected from CEACAM6, CEACAM8, CTSG, DEFA4, LTF, MMP8, OLFM4, OLR1, SHISA4, ABCA13, EMID1, LMOD1, MPO, and PRTN3 can be used as biomarkers in methods for the treatment of progressive fibrosing interstitial lung diseases.
    Type: Application
    Filed: March 30, 2021
    Publication date: May 4, 2023
    Inventors: Benjamin STROBEL, Patrick BAUM, Claudia DIEFENBACH
  • USE OF ECM BIOMARKERS FOR DETERMINING THE TREATMENT ONSET WITH NINTEDANIB AND PIRFENIDONE
    Publication number: 20190275032
    Abstract: The invention relates to a method for treating idiopathic pulmonary fibrosis using a compound selected from the group consisting of nintedanib, or a pharmaceutically acceptable salt thereof, and pirfenidone, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 26, 2017
    Publication date: September 12, 2019
    Inventors: Susanne STOWASSER, Claudia DIEFENBACH
  • USE OF ECM BIOMARKERS FOR DETERMINING THE TREATMENT ONSET WITH NINTEDANIB AND PIRFENIDONE
    Publication number: 20190275033
    Abstract: Disclosed is a method for treatment of idiopatic pulmonary fibrosis and progressive fibrosing interstitial lung disease (PF-ILD). In one embodiment, the method of the invention comprises administering nintedanib, or pharmaceutical acceptable salt thereof, and pirfenidone, or a pharmaceutical acceptable salt thereof to a patient in need thereof.
    Type: Application
    Filed: May 31, 2017
    Publication date: September 12, 2019
    Inventors: Susanne STOWASSER, Claudia DIEFENBACH
  • CENTROSOME-ASSAY
    Publication number: 20110091889
    Abstract: The present invention provides a centrosome assay for the identification of preferably, Eg5 inhibitors.
    Type: Application
    Filed: March 24, 2009
    Publication date: April 21, 2011
    Applicant: 4SC AG
    Inventors: Claudia Diefenbach, Matthias Vennemann, Astrid Grunwald